BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 6313596)

  • 21. Severe varicella-zoster virus meningoencephalomyelitis coexisting with visceral disseminated varicella-zoster virus infection in a patient with lupus nephritis: A case report.
    Tao T; Chen J; Long K; Zhi L; Zhang S; Liu S; Ma Y; Yan H; Lv L; Xu Y; Wu L; Zhao L; Gao P
    Medicine (Baltimore); 2023 Apr; 102(14):e33459. PubMed ID: 37026945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acyclovir treatment of varicella-zoster virus infection in the compromised host.
    Meyers JD; Wade JC; Shepp DH; Newton B
    Transplantation; 1984 Jun; 37(6):571-4. PubMed ID: 6328703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acyclovir therapy of varicella-zoster virus infections in the immunosuppressed children ].
    Peyramond D; Denoyel GA; Bertrand JL; Bertoye A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):596-602. PubMed ID: 6750532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory management of varicella-zoster virus infection in immunocompromised cancer patients.
    Rolston KV; Manzullo E; Elting L; Frisbee-Hume S; Rodriguez S; Rubenstein EB
    Support Care Cancer; 1998 Jan; 6(1):57-62. PubMed ID: 9458538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).
    Jacobson MA; Berger TG; Fikrig S; Becherer P; Moohr JW; Stanat SC; Biron KK
    Ann Intern Med; 1990 Feb; 112(3):187-91. PubMed ID: 2297195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acyclovir treatment prevents varicella-zoster virus replication in PBMC during viremia.
    Wolff MH; Schünemann S
    New Microbiol; 1999 Oct; 22(4):309-14. PubMed ID: 10555200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-time and low-dose intravenous acyclovir therapy in varicella zoster infections with malignant disease in children receiving combined chemotherapy.
    Sarialioğlu F; Buyukpamukcu M; Cevik N; Kutluk MT; Akyol H; Kansu E
    Pediatr Hematol Oncol; 1986; 3(3):267-71. PubMed ID: 3153239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.
    Wiegering V; Schick J; Beer M; Weissbrich B; Gattenlöhner S; Girschick HJ; Liese J; Schlegel PG; Eyrich M
    BMC Pediatr; 2011 May; 11():31. PubMed ID: 21569228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
    Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical aspects of chickenpox and herpes zoster.
    Balfour HH
    J Int Med Res; 1994; 22 Suppl 1():3A-12A; discussion 12A-13A. PubMed ID: 8063022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
    Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
    Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir halts progression of herpes zoster in immunocompromised patients.
    Balfour HH; Bean B; Laskin OL; Ambinder RF; Meyers JD; Wade JC; Zaia JA; Aeppli D; Kirk LE; Segreti AC; Keeney RE
    N Engl J Med; 1983 Jun; 308(24):1448-53. PubMed ID: 6343861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
    Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Varicella-zoster virus infections in the immunosuppressed child. Treatment with Acyclovir and controls].
    Peyramond D; Denoyel GA; Philip T; Souillet G; Philippe N; Bertrand JL; Bertoye A
    Arch Fr Pediatr; 1983 Feb; 40(2):95-9. PubMed ID: 6347116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients.
    Tayyar R; Ho D
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acyclovir therapy for acute herpes zoster.
    Bean B; Braun C; Balfour HH
    Lancet; 1982 Jul; 2(8290):118-21. PubMed ID: 6123837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella-zoster virus infection in immunocompromised patients.
    Masaoka T; Hiraoka A; Teshima H; Tominaga N
    J Med Virol; 1993; Suppl 1():82-4. PubMed ID: 8245898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.